University City Science Center has unveiled third class of its digital health accelerator that includes 7 companies developing technologies such as flushable pregnancy tests, remote patient monitoring systems, and augmented reality to prepare for emergency situations, among others.
The list includes the following companies:
- CareCierge – a high-tech/high-touch benefit for employees who struggle to balance work while caring for an ill or aging loved one. CareCierge provides employee caregivers with a personalized roadmap for care coordination and a trusted advisor to talk to, thereby reducing the lost productivity and increased healthcare expenditure that costs US businesses $47 billion per year.
- ImmERge Labs – uses virtual and augmented reality to reimagine how the world prepares for emergency situations. It aims to transform bystanders into rescuers through applications that integrate a physical manikin with highly realistic, multi-sensory simulations that technically, emotionally, and mentally prepare one to render life-saving interventions.
- LIA Diagnostics – the first-ever, flushable and biodegradable pregnancy test. The company plans to develop an app that will help facilitate purchases, further develop the Lia brand, and provide post-test education.
- PainQx – developer of a next-gen approach to objectively measure pain in humans. The company’s platform assesses neural activity from a patient’s brain, and processing and decoding the data through its proprietary algorithms. The output is a pain biomarker that is directly correlated to a patient’s pain state.
- RegDesk – using machine learning and the largest global network of compliance experts, RegDesk’s MedTech and PharmBio clients can obtain reliable product-specific regulatory, reimbursement and market access insights globally, allowing for faster access to market, with reduced risk and lower cost.
- repisodic – enables hospitals and their patients to find high-quality, personalized post-acute care by offering the most comprehensive picture of these providers available anywhere — online for free. The company’s platform connects post-acute care providers with discharging hospitals, patients, and their families to coordinate care and improve outcomes.
- Semacare – a deep machine learning artificial intelligence platform that improves health outcomes by allowing for earlier diagnosis of serious heart conditions. Semacare’s cloud platform and portable clinical-grade ECG and Pulse Oximeter provides data for early heart failure and stroke prevention diagnosis, and monitoring Q-T prolongation (which is the key indicator of a heart condition that causes sudden death).
As part of the 12-month program, companies accepted to the program will each receive up to $50,000, along with professional mentorship, and networking opportunities with a variety of key healthcare stakeholders including insurers, pharmaceutical companies, hospitals and research institutions located in the Greater Philadelphia region. They will also receive membership at ic@3401 — a partnership between the Science Center and Drexel University, in collaboration with Ben Franklin Technology Partners of Southeastern Pennsylvania and Safeguard Scientifics.
Launched in 2014 by the Science Center, the DHA has received support from the Commonwealth of Pennsylvania’s Department of Community and Economic Development and the U.S. Small Business Administration Growth Accelerator Fund.
To date, the 13 companies in the first two classes of the DHA have gone from prototype to commercialization, creating over 160 new jobs, generating over $21 million in revenue, and raising more than $21 million in follow-on investment.